Literature DB >> 25266074

A decade of extended-criteria lung donors in a single center: was it justified?

Jana Somers1, David Ruttens, Stijn E Verleden, Bianca Cox, Alessia Stanzi, Elly Vandermeulen, Robin Vos, Bart M Vanaudenaerde, Geert M Verleden, Hans Van Veer, Willy Coosemans, Herbert Decaluwe, Philippe Nafteux, Paul De Leyn, Dirk E Van Raemdonck.   

Abstract

Despite a worldwide need to expand the lung donor pool, approximately 75% of lung offers are not accepted for transplantation. We investigated the impact of liberalizing lung donor acceptance criteria during the last decade on the number of effective transplants and early and late outcomes in our center. All 514 consecutive lung transplants (LTx) performed between Jan 2000 and Oct 2011 were included. Donors were classified as matching standard criteria (SCD; n = 159) or extended criteria (ECD; n = 272) in case they fulfilled at least one of the following criteria: age >55 years, PaO2 /FiO2 at PEEP 5 cmH2 O < 300 mmHg at time of offer, presence of abnormalities on chest X-ray, smoking history, presence of aspiration, presence of chest trauma, or donation after circulatory death. Outcome parameters were primary graft dysfunction (PGD) grade at 0, 12, 24, and 48 h after LTx, time to extubation, stay in intensive care unit (ICU), early and late infection, acute rejection and bronchiolitis obliterans syndrome (BOS), and survival. Two hundred and seventy-two recipients (63.1%) received ECD lungs. PGD grade at T0 was similar between groups, while at T12 (<0.01), T24 (<0.01), and T48 (<0.05), PGD3 was observed more often in ECDs. ICU stay (P < 0.05) was longer in ECDs compared with SCDs. Time to extubation, respiratory infections, acute rejection, lymphocytic bronchiolitis, BOS, and survival were not different between groups. Accepting ECDs contributed in increasing the number of lung transplants performed in our center. Although this lung donor strategy has an impact on early postoperative outcome, liberalizing criteria did not influence long-term outcome after LTx.
© 2014 Steunstichting ESOT.

Entities:  

Keywords:  early post-transplant outcome; extended-criteria donor; late post-transplant outcome; lung donors; lung transplantation; thoracic surgery

Mesh:

Year:  2014        PMID: 25266074     DOI: 10.1111/tri.12470

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  22 in total

Review 1.  History of lung transplantation.

Authors:  Federico Venuta; Dirk Van Raemdonck
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

2.  Starting a lung transplant program: a roadmap for long-term excellence.

Authors:  Julia Klesney-Tait; Michael Eberlein; Lois Geist; John Keech; Joseph Zabner; Peter J Gruber; Mark D Iannettoni; Kalpaj Parekh
Journal:  Chest       Date:  2015-05       Impact factor: 9.410

Review 3.  The Future of Lung Transplantation.

Authors:  Katherine A Young; Daniel F Dilling
Journal:  Chest       Date:  2018-08-29       Impact factor: 9.410

4.  Procedure Preference and Intention-to-Treat Outcomes after Listing for Lung Transplantation among U.S. Adults. A Cohort Study.

Authors:  Michaela R Anderson; Ashley Tabah; Arindam RoyChoudhury; David J Lederer
Journal:  Ann Am Thorac Soc       Date:  2019-02

Review 5.  Evaluation and Management of the Potential Lung Donor.

Authors:  Andrew Courtwright; Edward Cantu
Journal:  Clin Chest Med       Date:  2017-08-31       Impact factor: 2.878

6.  Expanding the donor pool for lung transplantation using HCV-positive donors.

Authors:  Hrishikesh S Kulkarni; Kevin M Korenblat; Daniel Kreisel
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

7.  Low-risk donor lungs optimize the post-lung transplant outcome for high lung allocation score patients.

Authors:  Takeshi Kurosaki; Kentaroh Miyoshi; Shinji Otani; Kentaro Imanishi; Seiichiro Sugimoto; Masaomi Yamane; Motomu Kobayashi; Shinichi Toyooka; Takahiro Oto
Journal:  Surg Today       Date:  2018-05-11       Impact factor: 2.549

Review 8.  Lung cancer: a rare indication for, but frequent complication after lung transplantation.

Authors:  Dirk Van Raemdonck; Robin Vos; Jonas Yserbyt; Herbert Decaluwe; Paul De Leyn; Geert M Verleden
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

9.  Parametric Response Mapping of Bronchiolitis Obliterans Syndrome Progression After Lung Transplantation.

Authors:  S E Verleden; R Vos; E Vandermeulen; D Ruttens; H Bellon; T Heigl; D E Van Raemdonck; G M Verleden; V Lama; B D Ross; C J Galbán; B M Vanaudenaerde
Journal:  Am J Transplant       Date:  2016-07-29       Impact factor: 8.086

10.  Residual endotoxin induces primary graft dysfunction through ischemia/reperfusion-primed alveolar macrophages.

Authors:  Mahzad Akbarpour; Emilia Lecuona; Stephen F Chiu; Qiang Wu; Melissa Querrey; Ramiro Fernandez; Félix L Núñez-Santana; Haiying Sun; Sowmya Ravi; Chitaru Kurihara; James M Walter; Nikita Joshi; Ziyou Ren; Scott C Roberts; Alan Hauser; Daniel Kreisel; Wenjun Li; Navdeep S Chandel; Alexander V Misharin; Thalachallour Mohanakumar; G R Scott Budinger; Ankit Bharat
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.